Pfizer and BioNTech on Tuesday officially announced they have begun submitting data to US regulators seeking emergency use authorization (EUA) of their COVID-19 vaccine for children under age 5.
The Washington Post reported late on Monday that Pfizer and BioNTech would submit the request to the US Food and Drug Administration (FDA) as soon as Tuesday. If approved, the vaccine would be the only one approved for use in infants.
Read more